These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 26498267)

  • 41. Codonopsis lanceolata polysaccharide CLPS alleviates high fat/high sucrose diet-induced insulin resistance via anti-oxidative stress.
    Zhang Y; Wang H; Zhang L; Yuan Y; Yu D
    Int J Biol Macromol; 2020 Feb; 145():944-949. PubMed ID: 31669275
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Protective effect of ursodeoxycholic acid, resveratrol, and N-acetylcysteine on nonalcoholic fatty liver disease in rats.
    Ali MH; Messiha BA; Abdel-Latif HA
    Pharm Biol; 2016 Jul; 54(7):1198-208. PubMed ID: 26134756
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Protective and therapeutic effects of Crataegus aronia in non-alcoholic fatty liver disease.
    Al Humayed S
    Arch Physiol Biochem; 2017 Feb; 123(1):23-30. PubMed ID: 27424611
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nitric oxide mediates the insulin sensitizing effects of β-sitosterol in high fat diet-fed rats.
    Radika MK; Viswanathan P; Anuradha CV
    Nitric Oxide; 2013 Aug; 32():43-53. PubMed ID: 23624268
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adzuki bean ameliorates hepatic lipogenesis and proinflammatory mediator expression in mice fed a high-cholesterol and high-fat diet to induce nonalcoholic fatty liver disease.
    Kim S; Hong J; Jeon R; Kim HS
    Nutr Res; 2016 Jan; 36(1):90-100. PubMed ID: 26773785
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epigallocatechin gallate attenuated non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet.
    Ding Y; Sun X; Chen Y; Deng Y; Qian K
    Eur J Pharmacol; 2015 Aug; 761():405-12. PubMed ID: 25967348
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Suppression by fucoidan of liver fibrogenesis via the TGF-β/Smad pathway in protecting against oxidative stress.
    Hong SW; Jung KH; Lee HS; Zheng HM; Choi MJ; Lee C; Hong SS
    Biosci Biotechnol Biochem; 2011; 75(5):833-40. PubMed ID: 21597183
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Potential involvement of JNK1 repression in the hepatic effect of sitagliptin and metformin in rats subjected to high fat diet and chronic mild distress.
    Magdy YM; El-Kharashi OA; Nabih ES; Shaker SM; Abd-Elaziz LF; Aboul-Fotouh S
    Biomed Pharmacother; 2017 Jan; 85():225-238. PubMed ID: 27916420
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chrysin ameliorates nonalcoholic fatty liver disease in rats.
    Pai SA; Munshi RP; Panchal FH; Gaur IS; Juvekar AR
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Dec; 392(12):1617-1628. PubMed ID: 31372694
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Does propolis have any effect on non-alcoholic fatty liver disease?
    Kismet K; Ozcan C; Kuru S; Gencay Celemli O; Celepli P; Senes M; Guclu T; Sorkun K; Hucumenoglu S; Besler T
    Biomed Pharmacother; 2017 Jun; 90():863-871. PubMed ID: 28437890
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Deletion of Nrf2 leads to hepatic insulin resistance via the activation of NF-κB in mice fed a high-fat diet.
    Liu Z; Dou W; Ni Z; Wen Q; Zhang R; Qin M; Wang X; Tang H; Cao Y; Wang J; Zhao S
    Mol Med Rep; 2016 Aug; 14(2):1323-31. PubMed ID: 27315552
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Carnosic acid protects non-alcoholic fatty liver-induced dopaminergic neuron injury in rats.
    Xu T; Zhou J; Zhu J; Zhang S; Zhang N; Zhao Y; Ding C; Shi X; Yao J
    Metab Brain Dis; 2017 Apr; 32(2):483-491. PubMed ID: 27957651
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hepatic microvascular dysfunction and increased advanced glycation end products are components of non-alcoholic fatty liver disease.
    Pereira ENGDS; Silvares RR; Flores EEI; Rodrigues KL; Ramos IP; da Silva IJ; Machado MP; Miranda RA; Pazos-Moura CC; Gonçalves-de-Albuquerque CF; Faria-Neto HCC; Tibiriça E; Daliry A
    PLoS One; 2017; 12(6):e0179654. PubMed ID: 28628674
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diosmin ameliorates inflammation, insulin resistance, and fibrosis in an experimental model of non-alcoholic steatohepatitis in rats.
    Gerges SH; Wahdan SA; Elsherbiny DA; El-Demerdash E
    Toxicol Appl Pharmacol; 2020 Aug; 401():115101. PubMed ID: 32512072
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of resveratrol on experimental non-alcoholic steatohepatitis.
    Heebøll S; Thomsen KL; Clouston A; Sundelin EI; Radko Y; Christensen LP; Ramezani-Moghadam M; Kreutzfeldt M; Pedersen SB; Jessen N; Hebbard L; George J; Grønbæk H
    Pharmacol Res; 2015; 95-96():34-41. PubMed ID: 25814186
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of combined PPAR-γ and PPAR-α agonist therapy on fructose induced NASH in rats: Modulation of gene expression.
    Abd El-Haleim EA; Bahgat AK; Saleh S
    Eur J Pharmacol; 2016 Feb; 773():59-70. PubMed ID: 26825546
    [TBL] [Abstract][Full Text] [Related]  

  • 57. PPARα/γ agonists and antagonists differently affect hepatic lipid metabolism, oxidative stress and inflammatory cytokine production in steatohepatitic rats.
    Zhang Y; Cui Y; Wang XL; Shang X; Qi ZG; Xue J; Zhao X; Deng M; Xie ML
    Cytokine; 2015 Sep; 75(1):127-35. PubMed ID: 26194065
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The combined effect of metformin and L-cysteine on inflammation, oxidative stress and insulin resistance in streptozotocin-induced type 2 diabetes in rats.
    Salman ZK; Refaat R; Selima E; El Sarha A; Ismail MA
    Eur J Pharmacol; 2013 Aug; 714(1-3):448-55. PubMed ID: 23845213
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Altered distribution of regulatory lymphocytes by oral administration of soy-extracts exerts a hepatoprotective effect alleviating immune mediated liver injury, non-alcoholic steatohepatitis and insulin resistance.
    Khoury T; Ben Ya'acov A; Shabat Y; Zolotarovya L; Snir R; Ilan Y
    World J Gastroenterol; 2015 Jun; 21(24):7443-56. PubMed ID: 26139990
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dimethyl dimethoxy biphenyl dicarboxylate attenuates hepatic and metabolic alterations in high fructose-fed rats.
    Morsy MA; Ibrahim MA; Abd-Elghany MI
    Toxicol Ind Health; 2016 Jan; 32(1):59-67. PubMed ID: 24021431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.